An Australian pharmaceutical firm that is developing the first virus-killing nasal spray for colds is set to be listed on the ASX on Jan. 28. Firebrick Pharma co-founder Peter Molloy said he’s been working on the spray, Nasodine, for almost ten years as a treatment for the common cold. “It appeared to me that if…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`